NEOS Investment Management LLC Has $3.23 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

NEOS Investment Management LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 30.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,744 shares of the company’s stock after acquiring an additional 2,487 shares during the quarter. NEOS Investment Management LLC’s holdings in HCA Healthcare were worth $3,225,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Eagle Investment Management LLC grew its holdings in shares of HCA Healthcare by 0.5% during the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after buying an additional 23,177 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of HCA Healthcare by 11.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after purchasing an additional 174,946 shares during the period. Royal London Asset Management Ltd. boosted its holdings in shares of HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock worth $450,461,000 after purchasing an additional 574,239 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of HCA Healthcare by 2.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after acquiring an additional 41,190 shares during the last quarter. Finally, Janus Henderson Group PLC raised its stake in shares of HCA Healthcare by 12.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after purchasing an additional 143,995 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.0 %

HCA opened at $342.25 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a market capitalization of $84.26 billion, a P/E ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm’s fifty day moving average price is $324.53 and its two-hundred day moving average price is $341.56.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm earned $5.90 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Morgan Stanley lowered their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Bank of America decreased their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Finally, KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.